Skip to main content

News and announcements for C3PNO.

New Funding Opportunity: High Priority HIV and Substance Use Research

The National Institute of Health (NIH) has announced a new funding opportunity, "High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)" (RFA-DA-22-040). The purpose of this initiative is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use.

Read More

National Ending the HIV Epidemic (EHE) 2021 Meeting

On April 14-15, 2021, more than 300 academic investigators, government scientists, local health department professionals, and community members from throughout the U.S. participated in the virtual National Ending the HIV Epidemic (EHE) Meeting hosted by the National Institutes of Health (NIH) and the DC Center for AIDS Research (CFAR).

The meeting featured presentations by academic investigators and their implementation and community partners funded through NIH EHE awards and highlighted their data and experiences to date. In addition, Implementation Science Coordination, Consultation, & Collaboration Initiative (ISC3I) hosted a series of methods workshops for HIV implementation research and practice for the 2020 EHE project teams.

Read More

New Funding Opportunity: Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities

The National Institute of Health (NIH) has announced a new funding opportunity, "Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities" (RFA-MD-21-004). This initiative will support (1) observational research to understand the role of structural racism and discrimination (SRD) in causing and sustaining health disparities, and (2) intervention research that addresses SRD in order to improve minority health or reduce health disparities. Many topics for this opportunity are of interest to HIV and substance misuse research.

A letter of intent is due July 20, 2021. Applications are due August 24, 2021.

Read More

NIDA AIDS Research Program Symposium on the HIV/AIDS Avenir Award Program

Join the NIDA AIDS Research Program (ARP) for a symposium on the Avenir Award Program for Research on Substance Use Disorders and HIV/AIDS. The online event will feature insights from NIDA leadership and research highlights from recent Avenir awardees. The Symposium will take place on Jan 27, 2021 09:00AM in Eastern Time and the registration can be found here:

Read More

COVID-19 - Federal Resources on HIV and Coronavirus

Across the country, HIV service organizations and providers are working with people with HIV to support adherence to antiretroviral medications during the COVID-19 pandemic and to maintain ongoing access to HIV testing, prevention, and care services. has curated a collection of key federal resources related to HIV and COVID-19 to assist in this effort. Information is regularly being updated as we learn more in this evolving situation.

Read More

COVID-19: Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus.

The National Institute on Drug Abuse (NIDA) has issued a Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19).

NIDA is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders.

Read More

NIDA Participation in "Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Optional)"

NIDA will be participating in PAR-20-036 "Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Optional)"

NIDA is interested in the following areas of research involving people who use drugs (PWUD) including key populations (e.g., MSM, TW, FSW, HRH) where drug use is a common contributing HIV risk:

Studies of epidemiology of HIV transmission or care indicators (testing, transmission networks, linkage to care, engagement, and suppression of viral load) that provide methods for increasing accuracy and speed of providing data actionable data at jurisdictional or national population levels with particular attention the role of drug use Read More

NIDA to reissue PAR-18-062: "Accelerating the Pace of Drug Abuse Research Using Existing Data" R01

The National Institute on Drug Abuse (NIDA) intends to reissue PAR-18-062 "Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)" to solicit applications proposing innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of substance using behaviors (defined as alcohol, tobacco, prescription and other substances) and related disorders, prevention of substance use and HIV, and health service utilization. For more information, view the reissue notice.

Read More

NIDA Announces Limited Competition Funding Opportunity

NIH Common Fund announces FY2020 funding opportunities for the NIH Director's Pioneer Award, New Innovator Award, Transformative Research Award, and Early Independence Award in the High-Risk, High-Reward Research program. The program provides unique opportunities for exceptionally creative scientists to pursue highly innovative approaches to address major challenges in biomedical or behavioral research. Any research topic relevant to the broad mission of NIH is welcome. NIH especially encourages applications from women and members of groups that are underrepresented in NIH-funded research. For more information, visit the High-Risk, High-Reward Research Program page.

Read More

NIDA Limited Competition Funding Opportunity Announcement

NIDA has made a new limited competition Funding Opportunity Announcement (FOA). The purpose of this FOA (RFA-DA-20-005) is to support the maintenance and expansion of existing NIDA-funded cohorts to continue addressing new emerging and/or high priority research on multidisciplinary aspects of HIV/AIDS and substance abuse in alignment with NIH-HIV research priorities.

Read More

NIH OBSSR Requests Feedback on Fact Sheet and Updated Accomplishments

NIH Office of Behavioral and Social Sciences Research (OBSSR) is updating a fact sheet that lists some key accomplishments of health-related behavioral and social sciences research. The NIH behavioral and social sciences staff seeks submissions of accomplishments, additional information to a submitted accomplishment, and/or votes on the ones that have had a substantial health impact and for which behavioral and social sciences research was critical to achieving. To submit, click here.

Read More

NIDA Request for Information on Strategic Plan

NIDA has published a request for information (RFI) that seeks wide input from the investigator community towards its HIV/AIDS strategic plan for research at the intersection of HIV/AIDS and substance use, misuse and addiction

Read More

OAR Website Redesign

The Office of AIDS Research (OAR) at the National Institutes of Health (NIH) has revamped its website with a fresh, new look and updated, reorganized content. The new site highlights the trans-NIH HIV/AIDS research priorities and the role OAR plays in developing and coordinating research initiatives across the NIH to address these priorities. The website also includes a list of NIH Institutes and Centers that conduct HIV/AIDS research.

Read More

C3PNO Preconference at the 22nd International AIDS Conference

On July 22, the Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) held a pre-conference event before the International AIDS Conference in Amsterdam, the Netherlands. The International AIDS Conference is the largest annual HIV conference in the world.

Read More